Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana H Quan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosisDiana H Quan, Alexander J Kwong, Philip M Hansbro, et al.
Plos One|December 11, 2014
Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open ScienceKatrina A Badiola, Diana H Quan, James A Triccas, et al.
Vaccine|March 14, 2021
Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicityDiana H Quan, Claudio Counoupas, Gayathri Nagalingam, et al.
Vaccines|February 24, 2024
Lung IL-17A-Producing CD4<sup>+</sup> T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis VaccinesErica L Stewart, Claudio Counoupas, Diana H Quan, et al.
Nanomaterials (Basel, Switzerland)|August 27, 2021
Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in MiceShuxiong Chen, Diana H Quan, Xiaonan T Wang, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against <i>Mycobacterium tuberculosis</i>Matt D Johansen, Shalini, Sumit Kumar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 6, 2025
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosisDiana H Quan, Trixie Wang, Elena Martinez, et al.
Journal of Applied Microbiology|October 12, 2024
Synergistic oral beta-lactam combinations for treating tuberculosisDiana H Quan, Trixie Wang, Elena Martinez, et al.
Scientific Reports|October 9, 2019
Bengamides display potent activity against drug-resistant Mycobacterium tuberculosisDiana H Quan, Gayathri Nagalingam, Ian Luck, et al.
International Journal of Pharmaceutics|March 22, 2022
Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatmentAhmed H Albariqi, Yuncheng Wang, Rachel Yoon Kyung Chang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosisDiana H Quan, Alexander J Kwong, Philip M Hansbro, et al.
Plos One|December 11, 2014
Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open ScienceKatrina A Badiola, Diana H Quan, James A Triccas, et al.
Vaccine|March 14, 2021
Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicityDiana H Quan, Claudio Counoupas, Gayathri Nagalingam, et al.
Vaccines|February 24, 2024
Lung IL-17A-Producing CD4<sup>+</sup> T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis VaccinesErica L Stewart, Claudio Counoupas, Diana H Quan, et al.
Nanomaterials (Basel, Switzerland)|August 27, 2021
Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in MiceShuxiong Chen, Diana H Quan, Xiaonan T Wang, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against <i>Mycobacterium tuberculosis</i>Matt D Johansen, Shalini, Sumit Kumar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 6, 2025
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosisDiana H Quan, Trixie Wang, Elena Martinez, et al.
Journal of Applied Microbiology|October 12, 2024
Synergistic oral beta-lactam combinations for treating tuberculosisDiana H Quan, Trixie Wang, Elena Martinez, et al.
Scientific Reports|October 9, 2019
Bengamides display potent activity against drug-resistant Mycobacterium tuberculosisDiana H Quan, Gayathri Nagalingam, Ian Luck, et al.
International Journal of Pharmaceutics|March 22, 2022
Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatmentAhmed H Albariqi, Yuncheng Wang, Rachel Yoon Kyung Chang, et al.
Pageof 2